BAO PHARMA

BAO PHARMA was established in December 2019 with a registered capital of 37 million RMB. It is a biopharmaceutical enterprise integrating drug research and development and production. BAO PHARMA has planned 55 mu of land in the Luodian Industrial Park in Baoshan District for industrialization construction, aiming to build a production site that meets GMP requirements and is suitable for producing complex biological products, especially recombinant protein drugs. The total investment in the new project exceeds 900 million RMB, with a planned total construction area of approximately 75,000 square meters. This includes a 16,000-square-meter mammalian expression recombinant protein bulk solution workshop, an 11,000-square-meter microbial expression recombinant protein bulk solution workshop, and a 2,300-square-meter formulation workshop. The project has officially started and is expected to complete Phase I construction within two years.The development vision of BAO PHARMA is to become a model of differentiated competition in the biopharmaceutical industry and a unicorn in niche markets, focusing on technical breakthroughs and developing advanced biopharmaceutical products with high technological barriers.